Detalhe da pesquisa
1.
Call for Action: Benzodiazepine Prescription Prevalence Analysis Shows Off-Label Prescription in One in Eleven Citizens.
Eur Addict Res
; 25(6): 320-329, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31494655
2.
Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications.
BMC Med
; 12: 98, 2014 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24927744
3.
Corrigendum to "Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications".
Biomed Res Int
; 2023: 9757348, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37065720
4.
Antipsychotic polypharmacy in a regional health service: a population-based study.
BMC Psychiatry
; 12: 42, 2012 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22587453
5.
Dealing With Immunoglobulin Shortages: A Rationalization Plan From Evidence-Based and Data Collection.
Front Public Health
; 10: 893770, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35664094
6.
Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries.
Front Pharmacol
; 13: 873556, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35865969
7.
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications.
Biomed Res Int
; 2021: 9996193, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34676266
8.
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications.
Expert Rev Pharmacoecon Outcomes Res
; 21(4): 527-540, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33535841
9.
Social determinants of prescribed and non-prescribed medicine use.
Int J Equity Health
; 9: 12, 2010 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20441578
10.
Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab.
Appl Health Econ Health Policy
; 18(1): 5-16, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31696433
11.
The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures.
Front Pharmacol
; 11: 591134, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33519450
12.
[Performance assessment of health services in Catalonia (Spain): evaluation of initial results of the Catalan healthcare service project]. / Análisis del desempeño de los servicios sanitarios de Cataluña: evaluación de los primeros resultados del proyecto demostrativo.
Gac Sanit
; 23(5): 465-72, 2009.
Artigo
em Espanhol
| MEDLINE | ID: mdl-19487053
13.
Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation.
Front Pharmacol
; 8: 497, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28878667
14.
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways.
Front Pharmacol
; 7: 305, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27733828
15.
Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future.
Front Pharmacol
; 7: 197, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27516740
16.
Different initiatives across Europe to enhance losartan utilization post generics: impact and implications.
Front Pharmacol
; 5: 219, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25339902
17.
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications.
Front Pharmacol
; 5: 106, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24987370
18.
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs.
Front Pharmacol
; 5: 109, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24959145
19.
Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?
Pharmaceuticals (Basel)
; 3(8): 2470-2494, 2010 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27713363
20.
Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications.
Expert Rev Pharmacoecon Outcomes Res
; 10(6): 707-22, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21155704